MS is characterized by lesions in the brain and the spinal cord. The authors further explained, “Multiple sclerosis (MS) is a complex disease of unclear, multifactorial etiology and lesion ...

In a new study, the extent of microstructural damage in patients with early relapsing-remitting multiple sclerosis (RRMS) was associated with worse disability and spinal cord atrophy at 5 years ...

Galler S, Stellmann JP, Young KL, et al. Improved lesion detection by using axial T2-weighted MRI with full spinal cord coverage in multiple sclerosis. AJNR Am J Neuroradiol. 2016;37:963-969.

People with multiple sclerosis, or MS, begin experiencing new health issues up to 15 years before the classic signs of the ...

In samples of the spinal cord from four deceased MS patients, 260 genes were simultaneously analyzed and the cellular architecture of the lesions could be determined.

In samples of the spinal cord from four deceased MS patients, 260 genes were simultaneously analyzed and the cellular architecture of the lesions could be determined.

What you need to know about getting a multiple sclerosis diagnosis, including the kinds of tests performed to determine whether or not you have MS, and what a delay in treatment could mean for you.

"In children with multiple sclerosis, teriflunomide tempers lesion growth." ScienceDaily. ScienceDaily, 30 November 2021. <www.sciencedaily.com / releases / 2021 / 11 / 211130174008.htm>.

Chitnis, T., et al. (2021) Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial.

In MS, the immune system attacks the protective covering around the nerves of the brain and spinal cord. This can lead to inflammation that causes damage or scarring, known as plaques or lesions.

BUFFALO, N.Y. – Brain lesions — areas of brain tissue that show damage from injury or disease — are the biomarker most widely used to determine multiple sclerosis disease progression. But an ...